Bacterial or virus co-infections with severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2) have been reported in many studies, however, the knowledge on Aspergillus co …

Invasive Pulmonary Aspergillosis (IPA) has been recognized as a possible secondary
infection complicating Coronavirus disease 2019 (COVID-19) and increasing mortality. The …

Background Invasive pulmonary aspergillosis (IPA) is a complication of respiratory bacterial
and viral infections such as coronavirus disease 2019 (COVID‐19). Patients/Methods In …

Background Invasive aspergillosis is a well‐known complication of severe influenza
pneumonia with acute respiratory distress syndrome (ARDS). However, recent studies are …

Pneumonia caused by severe acute respiratory syndrome coronavirus 2 emerged in China
at the end of 2019. Because of the severe immunomodulation and lymphocyte depletion …

Objectives Information on the recently COVID‐19‐associated pulmonary aspergillosis
(CAPA) entity is scarce. We describe eight CAPA patients, compare them to colonised ICU …

Pulmonary aspergillosis has been increasingly reported following severe respiratory viral
infections. Millions have been infected by SARS-CoV-2, placing large numbers of patients at …

Occurrence of putative invasive pulmonary aspergillosis was screened in 153 consecutive
adult intensive care unit (ICU) patients with respiratory samples addressed for mycological …

Aspergillus co-infection in patients with severe coronavirus disease 2019 (COVID-19)
pneumonia, leading to acute respiratory distress syndrome, has recently been reported. To …

Background COVID‐19–associated pulmonary aspergillosis (CAPA) has emerged as an
invasive fungal disease, often affecting previously immunocompetent, mechanically …